Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47
Page 1 of 1
Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47
Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD. Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47. Expert Opin Therap Targets. 2012;[Epub ahead of print] doi:10.1517/14728222.2013.733699
Similar topics
» Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation
» Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47
» Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1
» Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR
» CD47 deficiency confers cell and tissue radioprotection by activation of autophagy
» Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47
» Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1
» Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR
» CD47 deficiency confers cell and tissue radioprotection by activation of autophagy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum